Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Psychiatric disorders – page 45

  • 545 clinical trials
  • 252 recruiting
  • 147 conditions
  • 26 countries

Conditions in this area

147 conditions with trials, the busiest first

Dementia Alzheimer's type87Major depression57Schizophrenia39Depression35Narcolepsy19Cognitive disorder18Bipolar disorder16Autism spectrum disorder15Insomnia15Post-traumatic stress disorder14Psychotic disorder14Drug use disorder13Alcohol use disorder12Attention deficit hyperactivity disorder9Dementia9Obstructive sleep apnoea syndrome9Brain injury8Irritable bowel syndrome8Phenylketonuria8Bipolar I disorder7Drug dependence7Lennox-Gastaut syndrome7Anorexia nervosa6Anxiety6+123

Clinical trials in Psychiatric disorders

545 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

545 clinical trials

Schizophrenia

Not recruiting
Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Ulotaront
  • Sponsor:Sumitomo Pharma Co. Ltd.

Autism spectrum disorder

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Pitolisant
  • Sponsor:Bioprojet Pharma

Dementia Alzheimer's type

Not recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Florbetaben (18F)
  • Sponsor:Biogen Idec Research Limited

Isodicentric chromosome 15 syndrome+3

Not recruiting
InvestigationalNo placebo
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Soticlestat
  • Sponsor:Takeda Development Center Americas Inc.

Psychotic disorder

Not recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Cannabidiol
  • Sponsor:Region Hovedstaden

Major depression

Not recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Celecoxib
  • Sponsor:Amsterdam UMC Stichting

Dementia Alzheimer's type

Not recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Lecanemab
  • Sponsor:Washington University School Of Medicine

Erectile dysfunction

Not recruiting
Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Lib-01 Monohydrate
  • Sponsor:Dicot AB

Frontotemporal dementia

Not recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Latozinemab
  • Sponsor:Alector LLC

Post-traumatic stress disorder

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Doxazosin
  • Sponsor:Charite Universitaetsmedizin Berlin KöR

Bipolar I disorder

Not recruiting
Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:4-Hydroxy-N-Desmethyltamoxifen
  • Sponsor:Intas Pharmaceuticals Limited

Major depression

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Substances:Mebufotenin
  • Sponsor:GH Research Ireland Limited

Substances studied in this area

The therapies tested most often in Psychiatric disorders trials.

Sodium Chloride25 clinical trialsTrospium Chloride17 clinical trialsXanomeline Tartrate16 clinical trialsCannabidiol15 clinical trialsDry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol14 clinical trialsFlorquinitau (18F)14 clinical trialsOxytocin13 clinical trialsAripiprazole12 clinical trialsFlorbetaben (18F)12 clinical trials
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.